A Comparable Risk of Extensively Drug-resistant Typhoid Fever in the Pediatric Cohort During the COVID-19 Pandemic

Overview

Journal Int J Health Sci (Qassim)

Specialty General Medicine

Date 2024 Jan 8

PMID 38188899

Authors

Maria Khan

Maria Tasneem Khattak

Amina Gul

Muhammad Riaz

Fatima Tu Zahra

Affiliations

Soon will be listed here.

Abstract

Objective: The number of extremely drug-resistant (XDR) Salmonella typhi isolates is growing in the northwest of Pakistan, where health-care facilities are already under strain due to the coronavirus disease 2019 (COVID-19) issue. In Khyber Pakhtunkhwa, Pakistan, we currently describe the first widespread appearance of an XDR Salmonella typhi epidemic during the COVID-19 pandemic. This strain of Salmonella typhi is resistant to all first- and second-line drugs and even the third-generation cephalosporin.

Methods: Salmonella species isolated from pediatric blood samples shown a high level of resistance to the various antibiotic classes evaluated between November and December 2020. Gender, age, address, and clinical symptoms were among the demographic information that was recorded. A total of 562 blood cultures from symptomatic patients have been collected by the Pathology Laboratory at a tertiary care institution of Rehman Medical Institute, Peshawar. All samples have been processed in accordance with regulatory requirements and incubated in BacT/ALERT 3D.

Results: Of the 562 blood samples, 71 included Salmonella typhi, of which 66 (92.9%) and 5 (7%) were multidrug resistant (MDR) and XDR, respectively. Ciprofloxacin (100%), chloramphenicol (100%), ceftriaxone (100%), ampicillin (100%), and cotrimoxazole (93%) were completely resistant to all isolates. Azithromycin and carbapenems were effective against every Salmonella typhi isolate that was MDR or XDR. Males (76%) were more commonly affected than females (24%), and the frequency was substantially higher in children under 15 years of age (88%) than in adults ( = 0.0016).

Conclusion: The emergence of XDR Salmonella typhi with a high level of resistance is in fact alarming. Due to the lack of viable treatment alternatives, the current situation necessitates the immediate implementation of efficient preventive measures, such as campaigns for typhoid vaccination and food and water safety.

Citing Articles

Factors affecting poor prognosis of COVID-19 in people living with human immunodeficiency virus: A systematic review and meta-analysis of co-infection.

Jami S, Helwan A, Tarin T, Aysha M, Mobarak S Int J Health Sci (Qassim). 2025; 19(1):49-55.

PMID: 39760054 PMC: 11699234.

References

Djeghout B, Saha S, Sajib M, Tanmoy A, Islam M, Kay G . Ceftriaxone-resistant Salmonella Typhi carries an IncI1-ST31 plasmid encoding CTX-M-15. J Med Microbiol. 2018; 67(5):620-627. DOI: 10.1099/jmm.0.000727. View

Parry C, Ribeiro I, Walia K, Rupali P, Baker S, Basnyat B . Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities. BMJ. 2019; 364:k5322. PMC: 6340381. DOI: 10.1136/bmj.k5322. View

Klemm E, Shakoor S, Page A, Qamar F, Judge K, Saeed D . Emergence of an Extensively Drug-Resistant Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins. mBio. 2018; 9(1). PMC: 5821095. DOI: 10.1128/mBio.00105-18. View

Haqqi A, Khurram M, Din M, Aftab M, Ali M, Ahmed H . COVID-19 and Salmonella Typhi co-epidemics in Pakistan: A real problem. J Med Virol. 2020; 93(1):184-186. PMC: 7405091. DOI: 10.1002/jmv.26293. View

Crump J, Luby S, Mintz E . The global burden of typhoid fever. Bull World Health Organ. 2004; 82(5):346-53. PMC: 2622843. View

Makkar A, Gupta S, Khan I, Gupta R, Rajmohan K, Chopra H . Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study. Acta Medica (Hradec Kralove). 2019; 61(4):125-130. DOI: 10.14712/18059694.2018.130. View

Masuet-Aumatell C, Atouguia J . Typhoid fever infection - Antibiotic resistance and vaccination strategies: A narrative review. Travel Med Infect Dis. 2020; 40:101946. DOI: 10.1016/j.tmaid.2020.101946. View

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

Arora P, Thorlund K, Brenner D, Andrews J . Comparative accuracy of typhoid diagnostic tools: A Bayesian latent-class network analysis. PLoS Negl Trop Dis. 2019; 13(5):e0007303. PMC: 6527309. DOI: 10.1371/journal.pntd.0007303. View

10.

Mansoor H, Ahmed K, Fida S, Uzair M, Asghar A, Iqbal J . Gastrointestinal and Hepatobiliary Complications of Extensively Drug-Resistant Typhoid at a Tertiary Care Hospital in Pakistan. Cureus. 2020; 12(10):e11055. PMC: 7676445. DOI: 10.7759/cureus.11055. View

11.

Veeraraghavan B, Pragasam A, Bakthavatchalam Y, Ralph R . Typhoid fever: issues in laboratory detection, treatment options & concerns in management in developing countries. Future Sci OA. 2018; 4(6):FSO312. PMC: 6060388. DOI: 10.4155/fsoa-2018-0003. View

12.

Qamar F, Azmatullah A, Kazi A, Khan E, Zaidi A . A three-year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi A in Pakistan. J Infect Dev Ctries. 2014; 8(8):981-6. DOI: 10.3855/jidc.3817. View

13.

Awan U, Zahoor S, Ayub A, Ahmed H, Aftab N, Afzal M . COVID-19 and arboviral diseases: Another challenge for Pakistan's dilapidated healthcare system. J Med Virol. 2020; 93(7):4065-4067. PMC: 7753522. DOI: 10.1002/jmv.26668. View

14.

Kidgell C, Reichard U, Wain J, Linz B, Torpdahl M, Dougan G . Salmonella typhi, the causative agent of typhoid fever, is approximately 50,000 years old. Infect Genet Evol. 2003; 2(1):39-45. DOI: 10.1016/s1567-1348(02)00089-8. View

15.

Butaye P, Michael G, Schwarz S, Barrett T, Brisabois A, White D . The clonal spread of multidrug-resistant non-typhi Salmonella serotypes. Microbes Infect. 2006; 8(7):1891-7. DOI: 10.1016/j.micinf.2005.12.020. View

16.

Yousaf M, Zahir S, Riaz M, Hussain S, Shah K . Statistical analysis of forecasting COVID-19 for upcoming month in Pakistan. Chaos Solitons Fractals. 2020; 138:109926. PMC: 7247520. DOI: 10.1016/j.chaos.2020.109926. View

17.

Azhar A, Khalid A, Shah S . The Implications of Extensive Drug-resistant Typhoid Fever: A Case Report. Cureus. 2019; 11(6):e5032. PMC: 6716743. DOI: 10.7759/cureus.5032. View

18.

Ozaras R, Cirpin R, Duran A, Duman H, Arslan O, Bakcan Y . Influenza and COVID-19 coinfection: Report of six cases and review of the literature. J Med Virol. 2020; 92(11):2657-2665. DOI: 10.1002/jmv.26125. View

19.

Frenck Jr R, Nakhla I, Sultan Y, Bassily S, Girgis Y, David J . Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis. 2000; 31(5):1134-8. DOI: 10.1086/317450. View

20.

Yousafzai M, Qamar F, Shakoor S, Saleem K, Lohana H, Karim S . Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine. Clin Infect Dis. 2019; 68(Suppl 1):S16-S21. PMC: 6376099. DOI: 10.1093/cid/ciy877. View